Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Finance
January 07, 2019 12:00 AM

Do digital tools fail to show impact in high-risk, high-cost populations?

Rachel Z. Arndt
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Top-funded private digital health companies in the U.S. have yet to show that they significantly affect outcomes for high-risk populations, according to a new study.

    In general, these companies tended to publish studies on healthy populations—when they published studies at all. Many didn't, according to the researchers, whose paper was published in the January issue of Health Affairs.

    "These top-funded companies haven't demonstrated the kind of standard of evidence regarding impact that physicians, hospitals, patients and payers are probably looking for," said Kyan Safavi, lead author and the David F. Torchiana health policy and management fellow at the Massachusetts General Physicians Organization. Instead, they tend to study healthy populations, rather than high-risk, high-cost populations.

    But enthusiasm about digital health companies' products—including biosensors, artificial intelligence-based tools, and population health tools—is high, with venture funding numbers to prove it: In 2017, digital health companies raised almost $6 billion. The funding is driven partly by the hope that these technologies will increase connectivity, patient engagement, and coordination between patients and providers, according to the researchers.

    Whether they can do that in high-risk, high-cost populations is relatively unknown, though, with few published peer-reviewed studies on the matter. "We think right now we're in a validation phase of many of these technologies," said Adam Cohen, a co-author and the health technologies program manager at the Johns Hopkins University Applied Physics Laboratory. "What we hope is coming is a greater proof-of-efficacy phase after validation."

    The researchers looked at 20 digital health companies in the U.S. with the most private equity funding through April 15, 2017—a group that had median funding of $67.5 million and, altogether, 156 published studies on their products and services. Fewer than a third of those studies focused on patients with high-burden conditions or risk factors.

    One reason for this dearth of studies on high-risk, high-cost populations is because many digital health companies work with direct-to-consumer models. That often means that they sell products that promote wellness and target already healthy populations.

    What's more, there is no regulatory requirement for these companies to study high-risk, high-cost populations, Cohen said. Regulatory requirements could shift the environment to one that promotes studying high-risk, high-cost patients; value-based incentives for adoption could also do that, the researchers wrote in the study. "If value-based purchasing becomes the dominant model, digital health tools that have evidence-based value will be in demand," they wrote.

    But, they noted, the shift to value has been slow, and fee-for-service models still dominate. For that reason, they suggested directly giving providers incentives to adopt certain digital health tools, such as those that help them better coordinate care.

    "Overall, we think digital health holds great promise, such as the ability to reach millions of patients at scale and being relatively cheap," Safavi said. To meet that promise, he added, digital health companies must prove that what they're doing works, including in high-risk, high-cost populations.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Copy of transparencyhospital costs_0001_i copy_i.png
    Fines kicking in after slow start to hospital transparency rule
    vaccine-money_i.png
    U.S. diverts COVID-19 funds to secure vaccines amid stalemate
    Sponsored Content
    Daily Finance Newsletter: Sign up to receive daily news and data that has a direct impact on the business and financing of healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing